Henry Schein Posts Strongest Sales Growth in 15 Quarters
Event summary
- Henry Schein reported $3.4 billion in Q4 2025 sales, up 7.7% YoY.
- Full-year 2025 revenue hit $13.2 billion, a 4% increase from 2024.
- Non-GAAP net income for Q4 rose to $160 million, up 6.6% YoY.
- Company introduced 2026 guidance projecting 3-5% sales growth and mid-single-digit Adjusted EBITDA growth.
- Fred Lowery announced as incoming CEO.
The big picture
Henry Schein's robust Q4 and full-year 2025 results underscore the effectiveness of its BOLD+1 strategic plan, particularly in high-growth segments like global equipment and technology. The company's ability to navigate leadership transitions and maintain momentum will be critical as it aims to deliver on its 2026 guidance. With operations spanning 34 countries and a diverse product portfolio, Henry Schein remains a key player in the healthcare solutions market.
What we're watching
- Leadership Transition Impact
- How Fred Lowery's tenure as CEO will affect Henry Schein's strategic execution and growth trajectory.
- Market Expansion Dynamics
- Whether the company can sustain its strong performance in global equipment, specialty products, and technology segments.
- Financial Guidance Realization
- The pace at which Henry Schein achieves its 2026 financial guidance targets amid potential economic headwinds.
Related topics
